RECORDATI: PUBLIC DISCLOSURE (SUMMARY REPORT OF THE VOTES - ORDINARY GENERAL MEETING OF THE SHAREHOLDERS 20.04.2021)

NEWS RELEASE

RECORDATI: PUBLIC DISCLOSURE (SUMMARY REPORT OF THE VOTES - ORDINARY GENERAL MEETING OF THE SHAREHOLDERS 20.04.2021)

Milan, 22nd April 2021 - Please be informed that the summary report of the voting results related to the resolutions approved by the Ordinary General Meeting of the Shareholders on 20th April 2021, pursuant to article 125-quater of the Legislative Decree 58/98, is available to the public on the Company's website (www.recordati.it, in the area "Investors", section "Shareholders' Meetings") and on the "1info" storage mechanism (www.1info.it).

Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and the other C.I.S. countries, Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in several therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2020 was € 1,448.9 million, operating income was € 469.0 million and net income was € 355.0 million.

For further information:
Recordati website: www.recordati.com
Investor Relations	Media Relations
Federica De Medici	Studio Noris Morano
(39) 02 48787146	(39) 02 76004736, (39) 02 76004745
e-mail: [e-mail]	e-mail: [e-mail]

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Registered Office
Via Matteo Civitali, 1	Share Capital € 26.140.644,50 fully paid-up
20148 Milano, Italy	Milano, Monza, Brianza and Lodi Comp. Reg. No. 00748210150
Ph. (39) 02 487871	Tax Code/VAT No. 00748210150
Fax [phone]	Milano R.E.A. No. 401832
www.recordati.com

Company subject to the Management and Coordination Activity of Rossini Luxembourg S.àr.l